Covalon Technologies Ltd

Covalon maintains a strong liquidity position, with a current ratio of 6.8 and $7.26 million in cash and equivalents, which is well above the industry median. The company's liquidity FPT (free cash flow to total liabilities) is 0.44, indicating a solid ability to meet short-term obligations without external financing.

Profitability metrics show a return on equity (ROE) of 7.38% and a return on assets (ROA) of 6.27%, both of which are in line with the industry median for medical equipment firms. The company's gross margin is 63.1%, and its operating margin is 17.6%, suggesting efficient cost management and pricing power in its core markets.

Geographically, Covalon's revenue is concentrated in North America, with over 80% of total revenue derived from this region. The company has a limited presence in international markets, which may expose it to regional economic fluctuations and regulatory changes.

Looking ahead, Covalon is projected to grow revenue by 12.5% in the current fiscal year and 15.0% in the next, driven by expansion in its wound care product lines and increased adoption of its infection prevention solutions. The company's free cash flow has improved in recent quarters, supporting its growth initiatives.

The company's risk profile is low, with no immediate liquidity or dilution flags detected. The debt-to-equity ratio is 0.06, and the company has no near-term pressure for equity issuance. However, the high price-to-earnings ratio of 41.23 suggests that the market is pricing in significant future growth expectations, which may not materialize.

Recent filings and transcripts indicate that Covalon is focused on expanding its product portfolio and enhancing its manufacturing capabilities. The company has also been investing in research and development to support innovation in its core markets. No major regulatory or legal issues have been reported in the latest disclosures.

Revenue grew 13.8% annually over four years, demonstrating consistent top-line expansion in the medical equipment sector.

Operating and net margins significantly exceed cohort medians, indicating superior profitability relative to 335 peers.

The single analyst consensus price target implies 34.3% upside from the current market price of 2.16.

Long-term debt decreased substantially from 2021 to 2025, reducing leverage and strengthening the balance sheet position.

Cash conversion ranks in the bottom quartile of the cohort, indicating poor efficiency in generating cash from earnings.

Revenue C$6.9M, −15,7% YoY; Operating income −99,9% YoY.

• ▍Revenue C$6.9M, −15,7% YoY
• ▍Operating income −99,9% YoY
• ▍Net income −89,6% YoY
• ▍Free cash flow −453,5% YoY
• ▍Net margin 1.8%

Revenue C$8.7M, −2,0% YoY; Operating income −63,0% YoY.

• ▍Revenue C$8.7M, −2,0% YoY
• ▍Operating income −63,0% YoY
• ▍Net income −41,5% YoY
• ▍Free cash flow −49,2% YoY
• ▍Net margin 4.1%

Revenue C$8.4M, −9,2% YoY; Operating income −105,3% YoY.

• ▍Revenue C$8.4M, −9,2% YoY
• ▍Operating income −105,3% YoY
• ▍Net income −95,5% YoY
• ▍Free cash flow −110,3% YoY
• ▍Net margin 0.8%

Revenue C$7.6M, −9,8% YoY; Operating income −81,0% YoY.

• ▍Revenue C$7.6M, −9,8% YoY
• ▍Operating income −81,0% YoY
• ▍Net income −70,6% YoY
• ▍Free cash flow −58,9% YoY
• ▍Net margin 5.7%

Revenue C$8.2M; Operating income C$1.2M.

• ▍Revenue C$8.2M
• ▍Operating income C$1.2M
• ▍Net margin 14.8%

Revenue C$8.9M; Operating income C$664.4k.

• ▍Revenue C$8.9M
• ▍Operating income C$664.4k
• ▍Net margin 6.9%

Revenue C$32.8M, +5,3% YoY; Operating income −41,5% YoY.

• ▍Revenue C$32.8M, +5,3% YoY
• ▍Operating income −41,5% YoY
• ▍Net income −22,9% YoY
• ▍Free cash flow −33,1% YoY
• ▍Net margin 6.3%

Revenue C$31.2M, +17,2% YoY; Operating income +161,0% YoY.

• ▍Revenue C$31.2M, +17,2% YoY
• ▍Operating income +161,0% YoY
• ▍Net income +159,8% YoY
• ▍Free cash flow +167,4% YoY
• ▍Net margin 8.6%

Revenue C$26.6M, +46,6% YoY; Operating income +50,5% YoY.

• ▍Revenue C$26.6M, +46,6% YoY
• ▍Operating income +50,5% YoY
• ▍Net income +53,8% YoY
• ▍Free cash flow +48,3% YoY
• ▍Net margin -16.8%

Revenue C$18.1M, −7,2% YoY; Operating income −1 190,5% YoY.

• ▍Revenue C$18.1M, −7,2% YoY
• ▍Operating income −1 190,5% YoY
• ▍Net income −141,2% YoY
• ▍Free cash flow −1 087,8% YoY
• ▍Net margin -53.3%

Revenue C$19.6M; Operating income C$838.3k.

• ▍Revenue C$19.6M
• ▍Operating income C$838.3k
• ▍Net margin 120.0%